Evidence map›Paper›PMID 30939165›Full record

ArticlePloS one2019

Folate/homocysteine metabolism and lung cancer risk among smokers.

Anna Stanisławska-Sachadyn, Joanna Borzyszkowska, Michał Krzemiński, Alicja Janowicz, Rafał Dziadziuszko, Jacek Jassem, Witold Rzyman, Janusz Limon

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Folic acid: friend or foe in cancer therapy.The Journal of international medical research · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Maternal polymorphic loci of rs1979277International journal of reproductive biomedicine · 2021
    Article
  17. The Concept of Folic Acid in Health and Disease.Molecules (Basel, Switzerland) · 2021
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anna Stanisławska-SachadynDepartment of Biology and Genetics, Medical University of Gdańsk, Gdańsk, Poland.ORCID 0000-0002-9490-4582
Joanna BorzyszkowskaDepartment of Biology and Genetics, Medical University of Gdańsk, Gdańsk, Poland.
Michał KrzemińskiDepartment of Probability and Biomathematics, Gdańsk University of Technology, Gdańsk, Poland.
Alicja JanowiczDepartment of Thoracic Surgery, Medical University of Gdańsk, Gdańsk, Poland.
Rafał DziadziuszkoDepartment of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.
Jacek JassemDepartment of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland.
Witold RzymanDepartment of Thoracic Surgery, Medical University of Gdańsk, Gdańsk, Poland.
Janusz LimonDepartment of Biology and Genetics, Medical University of Gdańsk, Gdańsk, Poland.
Gdańsk Medical University · PLGdańsk University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFolate and homocysteine are involved in DNA synthesis and methylation processes, which are deregulated during carcinogenesis.

objectivesThe aim of this study was to assess the relationship between folate/homocysteine concentrations, the functional polymorphisms of folate/homocysteine genes and lung cancer risk among cigarette smokers. STUDY

designThe study included 132 lung cancer patients and 396 controls from northern Poland, matched by sex, age and smoking status. The median cigarette pack-years of smoking among both cases and controls was 30.0. Serum, red blood cell (RBC) folates and serum homocysteine concentrations were measured. The genotypes in selected polymorphic sites of the MTHFR, CBS, SHMT1, MTHFD1, MTRR, MTR, TYMS DHFR, TCN2, and SLC19A1 genes were determined. All study participants underwent scanning with low-dose computed tomography.

resultsSerum folate concentrations above the median (> 17.5 nmol/l among the healthy controls) were associated with an increased lung cancer risk (odds ratio [OR], 1.54, 95% confidence intervals [CI], 1.04-2.29, P = 0.031). An analogous trend was observed when the population was analysed after subdivision according to RBC folate concentrations, that is, above a value of 506.5 nmol/l (OR, 1.53; 95% CI, 0.95-2.47; P = 0.084). Additionally, in a subset of women, an increased risk of lung cancer development was associated with the SLC19A1 c.80AA genotype (c.80AA versus GG OR, 3.14; 95% CI, 1.32-7.46; P = P = 0.010).

conclusionThese results suggest that, in the population consisting of heavy smokers, high folate levels add to the cancerogenic effect of smoking.

Indexed as

AgedAge FactorsFemaleFolic AcidGenotypeHomocysteineHumansLung NeoplasmsMaleMiddle AgedOdds RatioPolandPolymorphism, Single NucleotideReduced Folate Carrier ProteinReproducibility of ResultsRisk FactorsFolic AcidHomocysteineReduced Folate Carrier ProteinSLC19A1 protein, human

Identifiers

PMID30939165
PMCPMC6445430
OpenAlexW2929643791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.